Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. (2016)
Attributed to:
Advancing therapeutics by exploiting single cell functional analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2015-208916
PubMed Identifier: 26933146
Publication URI: http://europepmc.org/abstract/MED/26933146
Type: Journal Article/Review
Volume: 75
Parent Publication: Annals of the rheumatic diseases
Issue: 6
ISSN: 0003-4967